Increased Expression of Matrix Metalloproteinases in the Uterine Cervix of Postmenopausal Women

Pamela Moalli, Wendy L. Klingensmith, Leslie A. Meyn
In: Journal of Lower Genital Tract Disease · 2003 · vol. 7(1) , pp. 36–43 · doi:10.1097/00128360-200301000-00009 · PMID:17051043 · W2018790559
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

OBJECTIVE.: To determine whether atrophy of the uterine cervix in menopausal women is associated with an increased expression of matrix metalloproteinases (MMP), a decrease in their counter regulatory proteins (tissue inhibitors of matrix metalloproteinase [TIMP]), and a decrease in type I collagen. MATERIALS AND METHODS.: A pilot study was performed on cervical stroma harvested from 10 premenopausal and 9 postmenopausal women undergoing a hysterectomy. The amount of pro-MMP-2 and pro-MMP-9 in protein extracts from the two groups was compared by gelatin zymography. The membrane-type (MT)1-MMP, TIMP-1, and TIMP-2 were quantitated by Western immunoblotting. Total collagen was estimated by measuring hydroxyproline content. A primary fibroblast culture was developed to study estrogen regulation of MMP expression in vitro. RESULTS.: Pro-MMP-2 and pro-MMP-9 were increased in postmenopausal extracts. No difference in the amount of MT1-MMP, TIMP-1, TIMP-2, or total collagen was detected. In primary cervical fibroblast cultures, only active MMP-2 was suppressed by estrogen. CONCLUSIONS.: The protein expression of pro-MMP-2 and pro-MMP-9 is increased in cervical stroma of postmenopausal women relative to premenopausal women.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (29)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK